ResMed to buy back $450 million in stock under ASR
ResMed will buy back $450 million of stock under an accelerated share repurchase agreement with Citibank, using a 20 million-share repurchase authorization from 2014.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.